Cetalus - HUMAN PHARMACEUTICALS

Pharmaceutical Consultancy India. New market entry in the European Union. Re-engineering of US Nutraceuticals business. Industry-first evidence based promotion for specialty nutraceutical in Europe. New animal health applications for specialty nutraceutical in key international markets. Repositioning of specialty nutraceuticals as OTx for global leadership. Position extension of human nutraceutical and serious immune modulator for Quality of Life Support in companion animals undergoing chemotherapy and radiation. Quantum leap in sales and profitability with new Animal Health business strategy in Asia. Reversed price decline for European product group. Reversed sales decline for global product with new formulations. Facilitated leadership of minority Animal Health Business with strategic acquisition. Reversed profit decline for global Animal Health Business with COGS rationalization. Protected European registration and reversed Asian trade barrier for US feed supplement. Enhanced valuation of Global Animal Health business with competitive registrations.
Pilot of proprietary cosmeceutical at world's most famous luxury store in Europe. Launching specialty nutraceuticals in medical foods.

Continental launch for leading international anti-diabetes company
Turn-around of loss making Asian Pharmaceuticals business
Out-licensing cardiovascular generic in South America to leap frog innovator product
Out-licensing oncology business in South America to achieve market-share leadership
Unique market-based pricing strategy in key international markets
Industry-first segmentation, portfolio prioritization and promotion in key Asian market
Re-positioning of cough, colds product to achieve leadership in key Asian market
Re-launch anti-inflammatories for successful commercialization in key Asian market
Addition of user group to reverse sales decline of colds medication in key Asian market